pmc logo imageJournal ListSearchpmc logo image
Logo of tcriskmanJournal URL: redirect3.cgi?&&auth=0l3XMuP3CDHjQVFJLOdghMolKbdtmwZWDnatZpkUy&reftype=publisher&artid=2500260&article-id=2500260&iid=170394&issue-id=170394&jid=370&journal-id=370&FROM=Article|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://dovepress.com/articles.php?journal_id=68
Ther Clin Risk Manag. 2008 June; 4(3): 649–652.
Published online 2008 June.
PMCID: PMC2500260
An “acquired” hemoglobin J variant in a sickle cell disease patient
Nawwar Swedan,1 Kathleen Nicol,2 Phylis Moder,2 and Samir Kahwash2
1Fellow in Transfusion Medicine, Ohio State University, Columbus, Ohio
2Department of Laboratory Medicine, Nationwide Children’s Hospital, Columbus, Ohio
Correspondence: Samir Kahwash Department of Laboratory Medicine, Nationwide Children’s Hospital, 700 Children’s Drive, Columbus, OH 43205, USA Tel +1 614 722 5427 Fax +1 614 722 5308 Email samir.kahwash/at/nationwidechildrens.org
Abstract
We report the case of a rare hemoglobin variant, “Hemoglobin J”, discovered while performing hemoglobin electrophoresis following exchange transfusion of a sickle cell disease patient. It is usual practice in our institution to confirm the hemoglobin S level in sickle cell disease patients after red cell exchange. The patient had received 5 red cell units and the source of this variant was traced back to two of those units. Due to the uncertain clinical impact of this variant, and the lack of specific guidelines, the two donors were deferred from future donations to our institution.
Keywords: hemoglobin J, sickle cell disease, transfusion